[Atrial fibrillation in the elderly]

Area of Science:

• Cardiology
• Geriatrics
• Neurology

Background:

• Atrial fibrillation prevalence increases with age.
• Anticoagulation is beneficial for elderly patients, even those at high risk of bleeding.
• Stroke prevention in this demographic is critical.

Purpose of the Study:

• To review current evidence on stroke prevention and symptom management in elderly adults with atrial fibrillation.
• To compare the efficacy and safety of different anticoagulation strategies.
• To evaluate alternative therapies for patients with contraindications to oral anticoagulants.

Main Methods:

• Literature review of studies on atrial fibrillation management in the elderly.
• Comparative analysis of direct oral anticoagulants (DOACs) versus warfarin.
• Assessment of antiplatelet therapy, left atrial appendix occlusion, rate control, rhythm control, and catheter ablation.

Main Results:

• Direct oral anticoagulants (DOACs) demonstrated lower risks of ischemic stroke, systemic embolism, major bleeding, and intracranial bleeding compared to warfarin.
• Antiplatelet therapy has a limited role in stroke prevention for this population.
• Lenient rate control is a reasonable strategy for symptom management, with rhythm control reserved for specific situations.
• Left atrial appendix occlusion and catheter ablation are potential alternatives for select patients.

Conclusions:

• Anticoagulation is recommended for elderly patients with atrial fibrillation, with DOACs offering a favorable risk-benefit profile over warfarin.
• Alternative strategies exist for patients unable to tolerate oral anticoagulants.
• A comprehensive approach considering rate/rhythm control and interventional procedures is essential for managing atrial fibrillation in the elderly.